APO Research
Talk to an analyst

APO RESEARCH · REPORT

Type 2 Diabetes

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Type 2 Diabetes Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025186 pages

Choose your research edition.

Industry ResearchType 2 Diabetes Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Type 2 Diabetes Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Type 2 Diabetes Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Type 2 Diabetes Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Type 2 Diabetes Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Type 2 Diabetes market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Type 2 Diabetes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Type 2 Diabetes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Type 2 Diabetes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Type 2 Diabetes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Type 2 Diabetes include Sanofi, Novo Nordisk, Merck, Eli Lily, AstraZeneca, Daiichi Sankyo, Boehringer Ingelheim, Biocon and Astellas Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Type 2 Diabetes market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Type 2 Diabetes and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Type 2 Diabetes sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Type 2 Diabetes market size, projected growth trends, production technologies, key applications, and end-use industries.

Type 2 Diabetes Segment by Company

Sanofi

Novo Nordisk

Merck

Eli Lily

AstraZeneca

Daiichi Sankyo

Boehringer Ingelheim

Biocon

Astellas Pharma

Type 2 Diabetes Segment by Type

DPP-4 Inhibitors

GLP-1 Receptor Agonists

SGLT-2 Inhibitors

Insulins

Type 2 Diabetes Segment by Application

Drugstore

Hospital

Others

Type 2 Diabetes Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Type 2 Diabetes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Type 2 Diabetes and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Type 2 Diabetes.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Type 2 Diabetes market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Type 2 Diabetes manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Type 2 Diabetes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Type 2 Diabetes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Type 2 Diabetes Industry Trends Table 2. Type 2 Diabetes Industry Drivers Table 3. Type 2 Diabetes Industry Opportunities and Challenges Table 4. Type 2 Diabetes Industry Restraints Table 5. Global Type 2 Diabetes Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Type 2 Diabetes Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Type 2 Diabetes Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Type 2 Diabetes Sales Market Share by Manufacturers Table 9. Global Type 2 Diabetes Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Type 2 Diabetes Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Type 2 Diabetes Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Type 2 Diabetes Manufacturers, Product Type & Application Table 13. Global Type 2 Diabetes Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Type 2 Diabetes by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of DPP-4 Inhibitors Table 17. Major Manufacturers of GLP-1 Receptor Agonists Table 18. Major Manufacturers of SGLT-2 Inhibitors Table 19. Major Manufacturers of Insulins Table 20. Global Type 2 Diabetes Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Type 2 Diabetes Sales by Type (2021-2026) & (k units) Table 22. Global Type 2 Diabetes Sales by Type (2027-2032) & (k units) Table 23. Global Type 2 Diabetes Sales Market Share by Type (2021-2026) Table 24. Global Type 2 Diabetes Sales Market Share by Type (2027-2032) Table 25. Global Type 2 Diabetes Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Type 2 Diabetes Revenue by Type (2021-2026) & (k units) Table 27. Global Type 2 Diabetes Revenue by Type (2027-2032) & (k units) Table 28. Global Type 2 Diabetes Revenue Market Share by Type (2021-2026) Table 29. Global Type 2 Diabetes Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Drugstore Table 31. Major Manufacturers of Hospital Table 32. Major Manufacturers of Others Table 33. Global Type 2 Diabetes Sales by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Type 2 Diabetes Sales by Application (2021-2026) & (k units) Table 35. Global Type 2 Diabetes Sales by Application (2027-2032) & (k units) Table 36. Global Type 2 Diabetes Sales Market Share by Application (2021-2026) Table 37. Global Type 2 Diabetes Sales Market Share by Application (2027-2032) Table 38. Global Type 2 Diabetes Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 39. Global Type 2 Diabetes Revenue by Application (2021-2026) & (k units) Table 40. Global Type 2 Diabetes Revenue by Application (2027-2032) & (k units) Table 41. Global Type 2 Diabetes Revenue Market Share by Application (2021-2026) Table 42. Global Type 2 Diabetes Revenue Market Share by Application (2027-2032) Table 43. Global Type 2 Diabetes Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Type 2 Diabetes Sales by Region (2021-2026) & (k units) Table 45. Global Type 2 Diabetes Sales Market Share by Region (2021-2026) Table 46. Global Type 2 Diabetes Sales Forecasted by Region (2027-2032) & (k units) Table 47. Global Type 2 Diabetes Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Type 2 Diabetes Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. North America Type 2 Diabetes Sales by Country (2021-2026) & (k units) Table 50. North America Type 2 Diabetes Sales by Country (2027-2032) & (k units) Table 51. Europe Type 2 Diabetes Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Europe Type 2 Diabetes Sales by Country (2021-2026) & (k units) Table 53. Europe Type 2 Diabetes Sales by Country (2027-2032) & (k units) Table 54. Asia Pacific Type 2 Diabetes Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Asia Pacific Type 2 Diabetes Sales by Country (2021-2026) & (k units) Table 56. Asia Pacific Type 2 Diabetes Sales by Country (2027-2032) & (k units) Table 57. South America, Middle East and Africa Type 2 Diabetes Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 58. South America, Middle East and Africa Type 2 Diabetes Sales by Country (2021-2026) & (k units) Table 59. South America, Middle East and Africa Type 2 Diabetes Sales by Country (2027-2032) & (k units) Table 60. Global Type 2 Diabetes Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Type 2 Diabetes Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Type 2 Diabetes Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Type 2 Diabetes Revenue Market Share by Region (2021-2026) Table 64. Global Type 2 Diabetes Revenue Market Share by Region (2027-2032) Table 65. Sanofi Company Information Table 66. Sanofi Business Overview Table 67. Sanofi Type 2 Diabetes Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Sanofi Type 2 Diabetes Product Portfolio Table 69. Sanofi Recent Development Table 70. Novo Nordisk Company Information Table 71. Novo Nordisk Business Overview Table 72. Novo Nordisk Type 2 Diabetes Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Novo Nordisk Type 2 Diabetes Product Portfolio Table 74. Novo Nordisk Recent Development Table 75. Merck Company Information Table 76. Merck Business Overview Table 77. Merck Type 2 Diabetes Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Merck Type 2 Diabetes Product Portfolio Table 79. Merck Recent Development Table 80. Eli Lily Company Information Table 81. Eli Lily Business Overview Table 82. Eli Lily Type 2 Diabetes Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Eli Lily Type 2 Diabetes Product Portfolio Table 84. Eli Lily Recent Development Table 85. AstraZeneca Company Information Table 86. AstraZeneca Business Overview Table 87. AstraZeneca Type 2 Diabetes Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. AstraZeneca Type 2 Diabetes Product Portfolio Table 89. AstraZeneca Recent Development Table 90. Daiichi Sankyo Company Information Table 91. Daiichi Sankyo Business Overview Table 92. Daiichi Sankyo Type 2 Diabetes Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Daiichi Sankyo Type 2 Diabetes Product Portfolio Table 94. Daiichi Sankyo Recent Development Table 95. Boehringer Ingelheim Company Information Table 96. Boehringer Ingelheim Business Overview Table 97. Boehringer Ingelheim Type 2 Diabetes Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Boehringer Ingelheim Type 2 Diabetes Product Portfolio Table 99. Boehringer Ingelheim Recent Development Table 100. Biocon Company Information Table 101. Biocon Business Overview Table 102. Biocon Type 2 Diabetes Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Biocon Type 2 Diabetes Product Portfolio Table 104. Biocon Recent Development Table 105. Astellas Pharma Company Information Table 106. Astellas Pharma Business Overview Table 107. Astellas Pharma Type 2 Diabetes Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Astellas Pharma Type 2 Diabetes Product Portfolio Table 109. Astellas Pharma Recent Development Table 110. Key Raw Materials Table 111. Raw Materials Key Suppliers Table 112. Type 2 Diabetes Distributors List Table 113. Type 2 Diabetes Customers List Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. Type 2 Diabetes Product Image Figure 2. Global Type 2 Diabetes Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Type 2 Diabetes Market Size (2021-2032) & (US$ Million) Figure 4. Global Type 2 Diabetes Sales (2021-2032) & (k units) Figure 5. Global Type 2 Diabetes Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Type 2 Diabetes Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. DPP-4 Inhibitors Image Figure 9. GLP-1 Receptor Agonists Image Figure 10. SGLT-2 Inhibitors Image Figure 11. Insulins Image Figure 12. Global Type 2 Diabetes Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Type 2 Diabetes Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Type 2 Diabetes Sales Market Share by Type (2021-2032) Figure 15. Global Type 2 Diabetes Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Type 2 Diabetes Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Type 2 Diabetes Revenue Market Share by Type (2021-2032) Figure 18. Drugstore Image Figure 19. Hospital Image Figure 20. Others Image Figure 21. Global Type 2 Diabetes Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Type 2 Diabetes Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Type 2 Diabetes Sales Market Share by Application (2021-2032) Figure 24. Global Type 2 Diabetes Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Type 2 Diabetes Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Type 2 Diabetes Revenue Market Share by Application (2021-2032) Figure 27. North America Type 2 Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 28. North America Type 2 Diabetes Sales Market Share by Country (2021-2032) Figure 29. U.S. Type 2 Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 30. Canada Type 2 Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 31. Mexico Type 2 Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Type 2 Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Type 2 Diabetes Sales Market Share by Country (2021-2032) Figure 34. Germany Type 2 Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 35. France Type 2 Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 36. U.K. Type 2 Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 37. Italy Type 2 Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 38. Netherlands Type 2 Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Type 2 Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Type 2 Diabetes Sales Market Share by Country (2021-2032) Figure 41. China Type 2 Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 42. Japan Type 2 Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 43. South Korea Type 2 Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 44. Southeast Asia Type 2 Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 45. India Type 2 Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 46. Australia Type 2 Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Type 2 Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Type 2 Diabetes Sales Market Share by Country (2021-2032) Figure 49. Brazil Type 2 Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 50. South Africa Type 2 Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 51. Saudi Arabia Type 2 Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 52. Turkey Type 2 Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 53. Argentina Type 2 Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 54. UAE Type 2 Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 55. Egypt Type 2 Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 56. Chile Type 2 Diabetes Sales and Growth Rate (2021-2032) & (k units) Figure 57. Global Type 2 Diabetes Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Type 2 Diabetes Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Type 2 Diabetes Revenue (2021-2032) & (US$ Million) Figure 60. North America Type 2 Diabetes Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Type 2 Diabetes Revenue (2021-2032) & (US$ Million) Figure 62. Europe Type 2 Diabetes Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Type 2 Diabetes Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Type 2 Diabetes Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Type 2 Diabetes Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Type 2 Diabetes Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Type 2 Diabetes Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Type 2 Diabetes Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • DPP-4 Inhibitors
  • GLP-1 Receptor Agonists
  • SGLT-2 Inhibitors
  • Insulins
Applications
  • Drugstore
  • Hospital
  • Others
Companies covered
  • Sanofi
  • Novo Nordisk
  • Merck
  • Eli Lily
  • AstraZeneca
  • Daiichi Sankyo
  • Boehringer Ingelheim
  • Biocon
  • Astellas Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Type 2 Diabetes Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Type 2 Diabetes Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Type 2 Diabetes Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Type 2 Diabetes Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Type 2 Diabetes Market Dynamics
  1. 2.1 Type 2 Diabetes Industry Trends
  2. 2.2 Type 2 Diabetes Industry Drivers
  3. 2.3 Type 2 Diabetes Industry Opportunities and Challenges
  4. 2.4 Type 2 Diabetes Industry Restraints
3 Type 2 Diabetes Market by Manufacturers
  1. 3.1 Global Type 2 Diabetes Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Type 2 Diabetes Sales by Manufacturers (2021-2026)
  3. 3.3 Global Type 2 Diabetes Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Type 2 Diabetes Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Type 2 Diabetes Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Type 2 Diabetes Manufacturers, Product Type & Application
  7. 3.7 Global Type 2 Diabetes Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Type 2 Diabetes Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Type 2 Diabetes Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Type 2 Diabetes Tier 1, Tier 2, and Tier 3
4 Type 2 Diabetes Market by Type
  1. 4.1 Type 2 Diabetes Type Introduction
  2. 4.1.1 DPP-4 Inhibitors
  3. 4.1.2 GLP-1 Receptor Agonists
  4. 4.1.3 SGLT-2 Inhibitors
  5. 4.1.4 Insulins
  6. 4.2 Global Type 2 Diabetes Sales by Type
  7. 4.2.1 Global Type 2 Diabetes Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Type 2 Diabetes Sales by Type (2021-2032)
  9. 4.2.3 Global Type 2 Diabetes Sales Market Share by Type (2021-2032)
  10. 4.3 Global Type 2 Diabetes Revenue by Type
  11. 4.3.1 Global Type 2 Diabetes Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Type 2 Diabetes Revenue by Type (2021-2032)
  13. 4.3.3 Global Type 2 Diabetes Revenue Market Share by Type (2021-2032)
5 Type 2 Diabetes Market by Application
  1. 5.1 Type 2 Diabetes Application Introduction
  2. 5.1.1 Drugstore
  3. 5.1.2 Hospital
  4. 5.1.3 Others
  5. 5.2 Global Type 2 Diabetes Sales by Application
  6. 5.2.1 Global Type 2 Diabetes Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Type 2 Diabetes Sales by Application (2021-2032)
  8. 5.2.3 Global Type 2 Diabetes Sales Market Share by Application (2021-2032)
  9. 5.3 Global Type 2 Diabetes Revenue by Application
  10. 5.3.1 Global Type 2 Diabetes Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Type 2 Diabetes Revenue by Application (2021-2032)
  12. 5.3.3 Global Type 2 Diabetes Revenue Market Share by Application (2021-2032)
6 Global Type 2 Diabetes Sales by Region
  1. 6.1 Global Type 2 Diabetes Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Type 2 Diabetes Sales by Region (2021-2032)
  3. 6.2.1 Global Type 2 Diabetes Sales by Region (2021-2026)
  4. 6.2.2 Global Type 2 Diabetes Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Type 2 Diabetes Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Type 2 Diabetes Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Type 2 Diabetes Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Type 2 Diabetes Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Type 2 Diabetes Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Type 2 Diabetes Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Type 2 Diabetes Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Type 2 Diabetes Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Type 2 Diabetes Revenue by Region
  1. 7.1 Global Type 2 Diabetes Revenue by Region
  2. 7.1.1 Global Type 2 Diabetes Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Type 2 Diabetes Revenue by Region (2021-2026)
  4. 7.1.3 Global Type 2 Diabetes Revenue by Region (2027-2032)
  5. 7.1.4 Global Type 2 Diabetes Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Type 2 Diabetes Revenue (2021-2032)
  8. 7.2.2 North America Type 2 Diabetes Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Type 2 Diabetes Revenue (2021-2032)
  11. 7.3.2 Europe Type 2 Diabetes Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Type 2 Diabetes Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Type 2 Diabetes Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Type 2 Diabetes Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Type 2 Diabetes Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Type 2 Diabetes Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Type 2 Diabetes Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Novo Nordisk
  8. 8.2.1 Novo Nordisk Company Information
  9. 8.2.2 Novo Nordisk Business Overview
  10. 8.2.3 Novo Nordisk Type 2 Diabetes Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Novo Nordisk Type 2 Diabetes Product Portfolio
  12. 8.2.5 Novo Nordisk Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck Type 2 Diabetes Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck Type 2 Diabetes Product Portfolio
  18. 8.3.5 Merck Recent Developments
  19. 8.4 Eli Lily
  20. 8.4.1 Eli Lily Company Information
  21. 8.4.2 Eli Lily Business Overview
  22. 8.4.3 Eli Lily Type 2 Diabetes Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Eli Lily Type 2 Diabetes Product Portfolio
  24. 8.4.5 Eli Lily Recent Developments
  25. 8.5 AstraZeneca
  26. 8.5.1 AstraZeneca Company Information
  27. 8.5.2 AstraZeneca Business Overview
  28. 8.5.3 AstraZeneca Type 2 Diabetes Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 AstraZeneca Type 2 Diabetes Product Portfolio
  30. 8.5.5 AstraZeneca Recent Developments
  31. 8.6 Daiichi Sankyo
  32. 8.6.1 Daiichi Sankyo Company Information
  33. 8.6.2 Daiichi Sankyo Business Overview
  34. 8.6.3 Daiichi Sankyo Type 2 Diabetes Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Daiichi Sankyo Type 2 Diabetes Product Portfolio
  36. 8.6.5 Daiichi Sankyo Recent Developments
  37. 8.7 Boehringer Ingelheim
  38. 8.7.1 Boehringer Ingelheim Company Information
  39. 8.7.2 Boehringer Ingelheim Business Overview
  40. 8.7.3 Boehringer Ingelheim Type 2 Diabetes Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Boehringer Ingelheim Type 2 Diabetes Product Portfolio
  42. 8.7.5 Boehringer Ingelheim Recent Developments
  43. 8.8 Biocon
  44. 8.8.1 Biocon Company Information
  45. 8.8.2 Biocon Business Overview
  46. 8.8.3 Biocon Type 2 Diabetes Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Biocon Type 2 Diabetes Product Portfolio
  48. 8.8.5 Biocon Recent Developments
  49. 8.9 Astellas Pharma
  50. 8.9.1 Astellas Pharma Company Information
  51. 8.9.2 Astellas Pharma Business Overview
  52. 8.9.3 Astellas Pharma Type 2 Diabetes Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Astellas Pharma Type 2 Diabetes Product Portfolio
  54. 8.9.5 Astellas Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Type 2 Diabetes Value Chain Analysis
  2. 9.1.1 Type 2 Diabetes Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Type 2 Diabetes Production Mode & Process
  6. 9.2 Type 2 Diabetes Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Type 2 Diabetes Distributors
  9. 9.2.3 Type 2 Diabetes Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst